prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE OF IMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: LEFT BREAST MASS. POST-OF DIAGNOSIS: OPERATIVE PROCEDURE: LEFT SEG MAST. CLINICAL HISTORY. MATERIAL SUBMITTED: LEFT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. routine sutures. TINAL DIAGNOSIS: LEFT SEGMENTAL MASTECTOMY. . INFILTRATING DUCTAL CARCINONA, 1.8 BY 1.5 BY 1.0 CM. ("A1-A4"), POOR RISTOLOGIC AND INTERMEDIATE NUCLEAR. GRADE WITH CENTRAL SYALINIZATION AND CALCIFICATION ("A3"). - DUCTAL CARCINOMA IN-SITU, COMEDO TYPE REPRESENTING LESS THAN 2% or TUMOR VOLUME ("A3,A4"). - FIBROCYSTIC CHANGES WITH FOCAL DUCTAL EPITHELIAL HYPERPLASIA. - SURGICAL MARGINS FREE OF TUMOR. NOTE ER/PR immunoperoxidase assay and HER-2/NEU will be performed on block "A4". s U P P L E M E T A L R E P o R T. My. signature below is attestation that I have reviewed all slides and agree with the findings as noted. below. IMMUNOPEROXTDASE IDENTIFICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE "A4". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGKN RECEPTOR (95%) AND PROGESTERONE RECEPTOR (90%). THEREFORE, BOTH ARE INTERPRETED AS POSITIVE. P P L E M E N T A L R x P o R T. My signature below is attestation that I have reviewed all slides and agree with the findinge as noted. below. c-erbB2 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON MAGEE SURGICAL FBLOCK "A4" (BREAST CANCER). USING A 1:300 DILUTION OF DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE TNTRACELLULAR DOMAIN or c-. erb#2) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED THEREFORE, c-erbB2. (HER-2/NEU) IS INTERPRITED AS NEGATIVE.

expanded version (tokens=986) : 
 Histological classification: 
- Infiltrating Ductal Carcinoma 
- Ductal Carcinoma In-Situ (Comedo type) 
- Fibrocystic changes with focal ductal epithelial hyperplasia 

Subtype: Luminal A 

Description of necrosis: Central sialization and calcification 

Tumor infiltrating lymphocytes: No mention 

Histological grade: Poor histologic and intermediate nuclear grade 

Nuclear grade: Intermediate 

Lymphovascular invasion: No mention 

Calcification: Present 

Receptor status: 
- Estrogen receptor positive (95%) 
- Progesterone receptor positive (90%) 
- HER-2/NEU negative 

Ancillary testing results: ER/PR immunoperoxidase assay and HER-2/NEU immunostaining were both performed on block "A4". Estrogen receptor and progesterone receptor were positive while HER-2/NEU was negative. Surgical margins were free of tumor. 

Main points: 
- The patient had a left breast mass and underwent a left segmental mastectomy procedure. 
- The histological diagnosis included infiltrating ductal carcinoma, ductal carcinoma in-situ (comedo type), and fibrocystic changes with focal ductal epithelial hyperplasia. 
- The tumor was categorized as poor histologic and intermediate nuclear grade with central sialization and calcification. 
- The subtype was Luminal A. 


prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1133) : 
 Left segmental mastectomy of a 1.8 cm by 1.5 cm by 1.0 cm luminal A subtype infiltrating ductal carcinoma and <2% ductal carcinoma in-situ (comedo type) with poor histologic and intermediate nuclear grade, central sialization, and calcification. The tumor was ER/PR-positive (95%/90%) and HER-2/NEU-negative with free surgical margins. No lymphovascular invasion was noted.

